From Scholar Rock’s Local Approach to Immune Disease Nabs $20M:

Nagesh Mahanthappa, CEO of Scholar Rock
Nagesh Mahanthappa, CEO of Scholar Rock

Nagesh Mahanthappa, CEO of Scholar Rock